The Dr ug Enforcement Administration is proposing to place the recently approved veterinary anesthetic alfaxalone in Schedule IV (78 Fed. Reg. 17895).   Alfaxalone (5 [alpha]-pregnan-3[alpha]-ol-11,20-dione), previously spelled alphaxalone, is a neurosteroid derivative of 11-alpha-hydroxy-progesterone with central nervous system depressant properties. In 2012, it was approved in t... Read More